Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 25, 2026.

Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda

Nicolette Nabukeera-Barungi, Peter Elyanu, Barbara Asire and 6 more

BMC Infectious Diseases · 2015 · CC BY

doi:10.1186/s12879-015-1265-5

Abstract

Background. Adolescents have gained increased attention because they are the only age group where HIV related mortality is going up. We set out to describe the level and factors associated with adherence to antiretroviral therapy (ART) as well as the 1 year retention in care among adolescents in 10 representative districts in Uganda. In addition, we explored the barriers and facilitators of adherence to ART among adolescents.

Methods. The study involved 30 health facilities from 10 representative districts in Uganda. We employed both qualitative and quantitative data collection methods in convergent design. The former involved Focus group discussions with adolescents living with HIV, Key informant interviews with various stakeholders and in depth interviews with adolescents. The quantitative involved using retrospective records review to extract the last recorded adherence level from all adolescents who were active in HIV care. Factors associated with adherence were extracted from the ART cards. For the 1 year retention in care, we searched the hospital records of all adolescents in the 30 facilities who had started ART 1 year before the study to find out how many were still in care.

Results. Out of 1824 adolescents who were active on ART, 90.4 % (N = 1588) had ≥95 % adherence recorded on their ART cards at their last clinic visit. Only location in rural health facilities was independently associated with poor adherence to ART (P = 0.008, OR 2.64 [1.28 5.43]). Of the 156 adolescents who started ART, 90 % (N = 141) were still active in care 1 year later. Stigma, discrimination and disclosure issues were the most outstanding of all barriers to adherence. Other barriers included poverty, fatigue, side effects, pill burden, depression among others. Facilitators of adherence mainly included peer support groups, counseling, supportive health care workers, short waiting time and provision of food and transport.

Conclusion. Adherence to ART was good among adolescents. Being in rural areas was associated with poor adherence to ART and 1 year retention in care was very good among adolescents who were newly started on ART. Stigma and disclosure issues continue to be the main barriers to adherence among adolescents.

References 43

  1. 1.

    UNAIDS. Joint United Nations Programme on HIV/AIDS. Global report. UNAIDS report on the global AIDS epidemic 2013. 2013.

    Not in our library

  2. 2.

    UNICEF. Opportunity in crisis: preventing HIV from early adolescence to young adulthood. UNICEF. 2011.

    Not in our library

  3. 3.

    UNAIDS, JUNPoHA. Global report: UNAIDS report on the global AIDS epidemic 2010. 2010.

    Not in our library

  4. 4.

    WHO. HIV and adolescents: guidance for HIV testing and counseling and care for adolescents living with HIV: recommendations for a public health approach and considerations for policy-makers and managers, Geneva Switzerland. 2013.

    Not in our library

  5. 5.

    Paterson D, Swindells S, Mohr J, Brester M, Verqis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.

    Not in our library10.7326/0003-4819-133-1-200007040-00004

  6. 6.

    Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181-1183.

    Not in our library10.1097/00002030-200106150-00015

  7. 7.

    Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for Human Immunodeficiency Virus—infected persons in clinical trials. Clin Infect Dis. 2002;34(8):1115-1121.

    Not in our library10.1086/339074

  8. 8.

    Gill CJ, Hamer DH, Simon JL, Thea DM, Sabin LL. No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS. 2005;19(12):1243-1249.

    Not in our library10.1097/01.aids.0000180094.04652.3b

  9. 9.

    Ekstrand ML, Shet A, Chandy S, Singh G, Shamsundar R, Madhavan V, et al. Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India. Int Health. 2011;3(1):27-34.

    Not in our library10.1016/j.inhe.2010.11.003

  10. 10.

    Gokarn A, Narkhede MG, Pardeshi GS, Doibale MK. Adherence to antiretroviral therapy. JAPI. 2012;60:17.

    Not in our library

  11. 11.

    WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. 2013.

    Not in our library

  12. 12.

    Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23:1397-1404.

    Not in our library10.1097/qad.0b013e32832b7dca

  13. 13.

    Geng EH, Nash D, Kambugu A, Martin JN, Zhang Y, Braitstein C, Christopoulos KA, et al. Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep. 2010;7(4):234-244.

    Not in our library10.1007/s11904-010-0061-5

  14. 14.

    Talisuna-Alamo S, Colebunders B, Ouma J, Sunday P, Ekoru K, Wabwire-MAngeni F, et al. Socioeconomic support reduces non retention in a comprehensive, community-based antiretroviral therapy program in Uganda. J Acquir Immune Defic Syndr. 2012;59:e52-e59.

    Not in our library10.1097/qai.0b013e318246e2aa

  15. 15.

    Kim SH, Gerver SM, Fidler S, Ward H, et al. Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis. AIDS. 2014;28(13):1945-1956.

    Not in our library10.1097/qad.0000000000000316

  16. 16.

    Chandwani S, Loenig LJ, Sill AM, Abramowitz S, Conner LC, D'Angelo L, et al. Predictors of antiretroviral medication adherence among a diverse cohort of adolescents with HIV. J Adolesc Health. 2012;51:242-251.

    Not in our library10.1016/j.jadohealth.2011.12.013

  17. 17.
    Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda. · 2011
    Not checked
  18. 18.

    Ndiaye M, Nyasulu P, Nguyen H, Lowenthal ED, Gross R, Nachega JB, et al. Risk factors for suboptimal antiretroviral therapy adherence in HIV-infected adolescents in Gaborone, Botswana: a pilot cross-sectional study. Patient Prefer Adherence. 2013;7:891-895.

    Not in our library10.2147/ppa.s47628

  19. 19.

    Foster C, Fidler S. Optimizing antiretroviral therapy in adolescents with perinatally acquired HIV-1 infection. Expert Rev Anti Infect Ther. 2010;8(12):1403-1416.

    Not in our library10.1586/eri.10.129

  20. 20.

    Wiens MO, MacLeod S, Musiime V, Senyonga M, Kizza R, Bakeera-Kitaka S, et al. Adherence to antiretroviral therapy in HIV-positive adolescents in Uganda assessed by multiple methods. Pediatr Drugs. 2012;14(5):331-335.

    Not in our library10.1007/bf03262238

  21. 21.

    Nabukeera-Barungi N, Kalyesubula I, Kekitinwa A, Byakika-Tusiime J, Musoke P. Adherence to antiretroviral therapy among children attending Mulago hospital in Uganda. Ann Trop Paediatr. 2007;27:123–31.

    Not in our library10.1179/146532807x192499

  22. 22.

    Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 1996;8:261-269.

    Not in our library10.1080/09540129650125696

  23. 23.

    Gao X, Nau DP, Rosenbluth SA, Scott V, Woodward C. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care. 2000;12:387-398.

    Not in our library10.1080/09540120050123783

  24. 24.

    Ministry of Health Uganda. Addendum to the antiretroviral treatment guidelines for Uganda. 2013.

    Not in our library

  25. 25.
    Patient retention in antiretroviral therapy programs up to three years on treatment in sub‐Saharan Africa, 2007–2009: systematic review · 2010
    No notice
  26. 26.

    United States Agency for International Development. Retention of adolescents living with HIV in care, treatment, and support programs in Uganda. HIVCore final report. 2014.

    Not in our library

  27. 27.

    The Republic of Uganda. Ministry of Heath. The Integrated National Guidelines on Antiretroviral Therapy, prevention of mother to child transmission of HIV and infant & young child feeding. Page 34. http://idi-makerere.com/resources/doc_view/63-2012-integrated-national guidelines

    Not in our library

  28. 28.

    The Republic Of Uganda. National HIV Care Registry (Pre-Anti Retroviral Therapy) Ministry of Health–AIDS Control Program Unit Registry. www.emtct-iatt.org/wp-content/uploads/2013/…/Pre-ART-Register1.pdf

    Not in our library

  29. 29.

    Republic Of Uganda Ministry of Health. The health management information system, volume 1 health unit procedure manual. 2010.

    Not in our library

  30. 30.

    Ministry of Health Uganda. Baseline adolescent HIV study report. 2013.

    Not in our library

  31. 31.

    Lowenthal ED, Bakeera-Kitaka S, Marukutira T, Chapman J, Goldrath K, Ferrand RA. Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges. Lancet Infect Dis. 2014;14(7):627-639.

    Not in our library10.1016/s1473-3099(13)70363-3

  32. 32.

    Martinez J, Bell D, Camacho R, Henry-Reid L, Bell M, Watson C, et al. Adherence to antiviral drug regimens in HIV-infected adolescent patients engaged in care in a comprehensive adolescent and young adult clinic. J Natl Med Assoc. 2000;92(2):55.

    Not in our library

  33. 33.

    Musiime V, Kayiwa J, Kiconco M, Tamale W, Alima H, Mugerwa H, et al. Response to antiretroviral therapy of HIV type 1-infected children in urban and rural settings of Uganda. AIDS Res Hum Retroviruses. 2012;28(12):1647-1657.

    Not in our library10.1089/aid.2011.0313

  34. 34.

    Atuyambe L, Mirembe F, Annika J, Kirumira EK, Faxelid E. Seeking safety and empathy: adolescent health seeking behavior during pregnancy and early motherhood in central Uganda. J Adolesc. 2009;32(4):781-796.

    Not in our library10.1016/j.adolescence.2008.10.012

  35. 35.

    Mbonye AK. Disease and health seeking patterns among adolescents in Uganda. Int J Adolesc Med Health. 2003;15(2):105-112.

    Not in our library10.1515/ijamh.2003.15.2.105

  36. 36.

    Massavon W, Barlow-Mosha L, Mugenyi L, McFarland W, Musoke P, Giaquinto C, et al. Factors determining survival and retention among HIV-infected children and adolescents in a community home-based care and a facility-based family-centred approach in Kampala, Uganda: a cohort study. ISRN AIDS. 2014;2014:852489. 13 pages. http://dx.doi.org/10.1155/2014/852489.

    Not in our library10.1155/2014/852489

  37. 37.

    Kasedde S, Luo C, McClure C, Chandan U. Reducing HIV and AIDS in adolescents: opportunities and challenges. Curr HIV/AIDS Rep. 2013;10:159-168.

    Not in our library10.1007/s11904-013-0159-7

  38. 38.

    Nglazi MD, Lawn SD, Kaplan R, Kranzer K, Orrell C, Wood R. Changes in programmatic outcomes during 7 years of scale-up at a community-based antiretroviral treatment service in South Africa. JAIDS. 2011;56(1):e1-e8.

    Not in our library10.1097/qai.0b013e3181ff0bdc

  39. 39.

    Bikaako-Kajura W, Luyirika E, Purcell DW, Downing J, Kaharuza F, Mermin J, et al. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav. 2006;10(1):85-93.

    Not in our library10.1007/s10461-006-9141-3

  40. 40.

    Reda AA, Biadgilign S. Determinants of adherence to antiretroviral therapy among HIV-infected patients in Africa. AIDS Res Treat. 2012;2012:574656.

    Not in our library10.1155/2012/574656

  41. 41.

    Biadgilign S, Deribew A, Amberbir A, Deribe K. Barriers and facilitators to antiretroviral medication adherence among HIV infected paediatric patients in Ethiopia: a qualitative study. Sahara J. 2012;6(4):148-154.

    Not in our library10.1080/17290376.2009.9724943

  42. 42.

    Buchanan AL, Montepiedra G, Sirois PA, Kammerer B, Gavier PA, Nichols SL, et al. Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report. Pediatrics. 2012;129(5):e1244-e1251.

    Not in our library10.1542/peds.2011-1740

  43. 43.

    Michaud PA, Suris JC, Thomas J, Gnehm HE, Cheseaux JJ, AND THE SWISS HIV MOTHER + CHILD COHORT STUDY. Coping with an HIV infection. A multicenter qualitative survey on HIV positive adolescents’ perceptions of their disease, therapeutic adherence and treatment. Swiss Med Wkly. 2010;140:247-253.

    Not in our library10.4414/smw.2010.12834

Cited by papers we hold 4

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.